2.0
Jul 13, 2012
Former employee, more than 1 year
Ramat Gan
Recommend
CEO approval
Business outlook
Pros
The product itself is simple in concept, and could make a big difference in the preemptive detection of one of the most aggressive cancer types there are (i.e., colon cancer).
Cons
There is some obscurity as to how a machine that has gone through FDA approval 2009 and got its CE is not yet in the market. I took part in its successes in human trials 2008-2009, which where very promising (success rate of exams was reported as better than the reference STD colonoscopy, performed).